Skip to main content
. 2004 Nov 9;384(Pt 1):149–157. doi: 10.1042/BJ20040928

Figure 2. Curcumin dose-dependently increases the abundance of PPARγ and pro-apoptotic Bax and decreases that of anti-apoptotic Bcl-2 in passaged HSC.

Figure 2

Passaged HSC were treated with curcumin at indicated concentrations for 24 h. Whole-cell protein extracts were prepared for Western blotting analyses (n=3). β-Actin was an internal control for equal loading.